WO2001074897A3 - Protein amf-1 to amf-10 and nucleic acids encoding the same - Google Patents

Protein amf-1 to amf-10 and nucleic acids encoding the same Download PDF

Info

Publication number
WO2001074897A3
WO2001074897A3 PCT/US2001/010892 US0110892W WO0174897A3 WO 2001074897 A3 WO2001074897 A3 WO 2001074897A3 US 0110892 W US0110892 W US 0110892W WO 0174897 A3 WO0174897 A3 WO 0174897A3
Authority
WO
WIPO (PCT)
Prior art keywords
amf
nucleic acids
protein
same
acids encoding
Prior art date
Application number
PCT/US2001/010892
Other languages
French (fr)
Other versions
WO2001074897A2 (en
Inventor
Corine A M Vernet
Catherine E Burgess
Elma Fernandes
Raymond J Taupier Jr
Kerry E Quinn
Kimberly Ann Spytek
Luca Rastelli
John L Herrmann
Original Assignee
Curagen Corp
Corine A M Vernet
Catherine E Burgess
Elma Fernandes
Raymond J Taupier Jr
Kerry E Quinn
Kimberly Ann Spytek
Luca Rastelli
John L Herrmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Corine A M Vernet, Catherine E Burgess, Elma Fernandes, Raymond J Taupier Jr, Kerry E Quinn, Kimberly Ann Spytek, Luca Rastelli, John L Herrmann filed Critical Curagen Corp
Priority to CA002404526A priority Critical patent/CA2404526A1/en
Priority to EP01923104A priority patent/EP1268540A2/en
Priority to JP2001572586A priority patent/JP2003529358A/en
Priority to AU2001249828A priority patent/AU2001249828A1/en
Publication of WO2001074897A2 publication Critical patent/WO2001074897A2/en
Publication of WO2001074897A3 publication Critical patent/WO2001074897A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein are novel human nucleic acid sequences which encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies which immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
PCT/US2001/010892 2000-04-03 2001-04-03 Protein amf-1 to amf-10 and nucleic acids encoding the same WO2001074897A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002404526A CA2404526A1 (en) 2000-04-03 2001-04-03 Protein amf-1 to amf-10 and nucleic acids encoding the same
EP01923104A EP1268540A2 (en) 2000-04-03 2001-04-03 Proteins amf-1 to amf-10 and nucleic acids encoding same
JP2001572586A JP2003529358A (en) 2000-04-03 2001-04-03 AMF-1 to AMF-10 proteins and nucleic acids encoding the proteins
AU2001249828A AU2001249828A1 (en) 2000-04-03 2001-04-03 Protein AMF-1 to AMF-10 nucleic acids encoding the same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19331400P 2000-04-03 2000-04-03
US19431400P 2000-04-03 2000-04-03
US60/194,314 2000-04-03
US22569300P 2000-08-16 2000-08-16
US60/225,693 2000-08-16

Publications (2)

Publication Number Publication Date
WO2001074897A2 WO2001074897A2 (en) 2001-10-11
WO2001074897A3 true WO2001074897A3 (en) 2002-06-20

Family

ID=27393184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/010892 WO2001074897A2 (en) 2000-04-03 2001-04-03 Protein amf-1 to amf-10 and nucleic acids encoding the same

Country Status (1)

Country Link
WO (1) WO2001074897A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4838961B2 (en) * 1999-09-21 2011-12-14 中外製薬株式会社 Transporter genes OATP-B, C, D, and E
AU2001263814A1 (en) * 2000-03-27 2001-10-08 Bayer Aktiengesellschaft Regulation of human oatp2-related protein
WO2001083781A2 (en) 2000-04-28 2001-11-08 Millennium Pharmaceuticals, Inc. 14094, a novel human trypsin family member and uses thereof
AU2001269013A1 (en) * 2000-05-18 2001-11-26 Bayer Aktiengesellschaft Human galanin receptor-like g protein coupled receptor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009797A1 (en) * 1987-06-05 1988-12-15 The United States Of America, As Represented By Th Autocrine motility factors in cancer diagnosis and management
US5449753A (en) * 1992-01-17 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis
WO1999061060A1 (en) * 1998-05-22 1999-12-02 Universite De Montreal Conjugates of an amf ligand and a cytotoxic molecule for use in cancer therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009797A1 (en) * 1987-06-05 1988-12-15 The United States Of America, As Represented By Th Autocrine motility factors in cancer diagnosis and management
US5449753A (en) * 1992-01-17 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Autotaxin: motility stimulating protein useful in cancer diagnosis
WO1999061060A1 (en) * 1998-05-22 1999-12-02 Universite De Montreal Conjugates of an amf ligand and a cytotoxic molecule for use in cancer therapy

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EM_EST [online] EMBL; 31 December 1998 (1998-12-31), STRAUSBERG, R. ET AL.: "Human cDNa clone IMAGE:2009218 3' , similar to fibrillin 1 precursor", XP002186022, retrieved from EBI accession no. AI341180 Database accession no. AI341180 *
DATABASE EM_EST [online] EMBL; 5 May 1999 (1999-05-05), STRAUSBERG, R. ET AL.: "Human cDNA clone IMAGE:2310224 3', similar to fibrilin 1 precursor", XP002186023, retrieved from EBI accession no. AI652723 Database accession no. AI652723 *
DATABASE SWISS-PROT [online] Swiss institute of Bioinformatics; 1 June 1994 (1994-06-01), ZHANG, H. ET AL., XP002186021, retrieved from EBI accession no. P35556 Database accession no. P35556 *

Also Published As

Publication number Publication date
WO2001074897A2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002006339A3 (en) Proteins and nucleic acids encoding same
WO2002014368A8 (en) Proteins and nucleic acids encoding the same
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002064791A3 (en) Proteins and nucleic acids encoding same
WO2002050277A3 (en) Protein and nucleic acids encoding same
WO2002057453A3 (en) Polypetides and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002057450A3 (en) Proteins and nucleic acids encoding same
WO2002098917A3 (en) Human proteins and nucleic acids encoding same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2002029058A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2001081578A3 (en) Novel proteins and nucleic acids encoding same
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2002029038A3 (en) Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002010216A3 (en) Proteins and nucleic acids encoding same
WO2002055702A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002046229A3 (en) Novel proteins and nucleic acids encoding same
WO2002066643A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001066747A3 (en) Proteins named fctrx and nucleic acids encoding same
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003040329A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002057452A3 (en) Human proteins, polynucleotides encoding them and methods of using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001249828

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2404526

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 572586

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001923104

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001923104

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001923104

Country of ref document: EP